Summary of Significant Accounting Policies (Tables)

6 Months Ended

Jun. 30, 2024

Accounting Policies [Abstract]

Schedules of Concentration of Risk, by Risk Factor

A significant customer is any biopharmaceutical customer, clinical testing payer, or international laboratory partner that represents 10% or more of the Company’s total revenue or accounts receivable balance. Revenue attributable to each significant customer, including its affiliated entities, as a percentage of the Company’s total revenue, for the respective period, and accounts receivable balance attributable to each significant customers, including its affiliated entities, as a percentage of the Company’s total accounts receivable balance, at the respective condensed consolidated balance sheet date, are as follows:

	Revenue								Accounts Receivable, Net
	Three Months Ended June 30,				Six Months Ended June 30,				June 30, 2024		December 31, 2023
	2024		2023		2024		2023
	(unaudited)								(unaudited)
Customer A	12	%	*		*		*		24	%	12	%
Customer B	29	%	32	%	30	%	32	%	*		12	%
Customer C	*		*		*		*		*		10	%

*    less than 10%